77 related articles for article (PubMed ID: 7489359)
21. Lost in migration.
Mack GS; Marshall A
Nat Biotechnol; 2010 Mar; 28(3):214-29. PubMed ID: 20212481
[No Abstract] [Full Text] [Related]
22. Structure-based engineering of species selectivity in the interaction between urokinase and its receptor: implication for preclinical cancer therapy.
Lin L; Gårdsvoll H; Huai Q; Huang M; Ploug M
J Biol Chem; 2010 Apr; 285(14):10982-92. PubMed ID: 20133942
[TBL] [Abstract][Full Text] [Related]
23. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.
Alix-Panabières C; Vendrell JP; Slijper M; Pellé O; Barbotte E; Mercier G; Jacot W; Fabbro M; Pantel K
Breast Cancer Res; 2009; 11(3):R39. PubMed ID: 19549321
[TBL] [Abstract][Full Text] [Related]
24. Cancer micrometastases.
Pantel K; Alix-Panabières C; Riethdorf S
Nat Rev Clin Oncol; 2009 Jun; 6(6):339-51. PubMed ID: 19399023
[TBL] [Abstract][Full Text] [Related]
25. Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.
Kita Y; Fukagawa T; Mimori K; Kosaka Y; Ishikawa K; Aikou T; Natsugoe S; Sasako M; Mori M
Br J Cancer; 2009 Jan; 100(1):153-9. PubMed ID: 19050704
[TBL] [Abstract][Full Text] [Related]
26. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
Allgayer H; Aguirre-Ghiso JA
APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.
Bogoevski D; Strate T; Yekebas EF; Izbicki JR
Langenbecks Arch Surg; 2008 Nov; 393(6):911-7. PubMed ID: 18202848
[TBL] [Abstract][Full Text] [Related]
28. Models, mechanisms and clinical evidence for cancer dormancy.
Aguirre-Ghiso JA
Nat Rev Cancer; 2007 Nov; 7(11):834-46. PubMed ID: 17957189
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients.
Oki E; Kakeji Y; Baba H; Nishida K; Koga T; Tokunaga E; Egashira A; Ikeda K; Yoshida R; Yamamoto M; Morita M; Maehara Y
J Cancer Res Clin Oncol; 2007 Dec; 133(12):995-1000. PubMed ID: 17588173
[TBL] [Abstract][Full Text] [Related]
30. Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C.
Pleyer L; Went P; Russ G; Prinz E; Faber V; Röwert HJ; Karlbauer R; Greil R
Wien Klin Wochenschr; 2007; 119(7-8):254-8. PubMed ID: 17492354
[TBL] [Abstract][Full Text] [Related]
31. Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy.
Ranganathan AC; Adam AP; Aguirre-Ghiso JA
Cell Cycle; 2006 Aug; 5(16):1799-807. PubMed ID: 16929185
[TBL] [Abstract][Full Text] [Related]
32. The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.
Aguirre-Ghiso JA
Cell Cycle; 2006 Aug; 5(16):1740-3. PubMed ID: 16929164
[TBL] [Abstract][Full Text] [Related]
33. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
Zhang L; Zhao ZS; Ru GQ; Ma J
World J Gastroenterol; 2006 Jul; 12(25):3970-6. PubMed ID: 16810742
[TBL] [Abstract][Full Text] [Related]
34. Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.
Wolfrum F; Vogel I; Fändrich F; Kalthoff H
Langenbecks Arch Surg; 2005 Sep; 390(5):430-41. PubMed ID: 15991048
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.
Llinas P; Le Du MH; Gårdsvoll H; Danø K; Ploug M; Gilquin B; Stura EA; Ménez A
EMBO J; 2005 May; 24(9):1655-63. PubMed ID: 15861141
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Pouillart P; Thiery JP
Br J Cancer; 2003 Aug; 89(3):539-45. PubMed ID: 12888827
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors.
Solakoglu O; Maierhofer C; Lahr G; Breit E; Scheunemann P; Heumos I; Pichlmeier U; Schlimok G; Oberneder R; Kollermann MW; Kollermann J; Speicher MR; Pantel K
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2246-51. PubMed ID: 11854519
[TBL] [Abstract][Full Text] [Related]
38. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.
Thorban S; Rosenberg R; Busch R; Roder RJ
Br J Cancer; 2000 Jul; 83(1):35-9. PubMed ID: 10883665
[TBL] [Abstract][Full Text] [Related]
39. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.
Yamaguchi K; Takagi Y; Aoki S; Futamura M; Saji S
Ann Surg; 2000 Jul; 232(1):58-65. PubMed ID: 10862196
[TBL] [Abstract][Full Text] [Related]
40. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
Shetty S; Idell S
Mol Cell Biochem; 1999 Sep; 199(1-2):189-200. PubMed ID: 10544967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
